🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/04/2022 | 82,19 | 83,58 | 81,64 | 83,52 | +1,79% | 2,36% | 10.086.700 |
| 31/03/2022 | 82,90 | 83,38 | 81,94 | 82,05 | -0,42% | 1,74% | 12.466.800 |
| 30/03/2022 | 81,84 | 82,70 | 81,67 | 82,40 | +1,02% | 1,26% | 9.326.600 |
| 29/03/2022 | 81,66 | 81,76 | 80,74 | 81,57 | +0,44% | 1,25% | 7.398.700 |
| 28/03/2022 | 81,37 | 81,67 | 80,73 | 81,21 | -0,16% | 1,16% | 7.071.900 |
| 25/03/2022 | 80,59 | 81,38 | 80,45 | 81,34 | +1,16% | 1,15% | 7.125.600 |
| 24/03/2022 | 80,04 | 80,67 | 79,72 | 80,41 | +0,85% | 1,19% | 7.605.000 |
| 23/03/2022 | 79,30 | 80,58 | 79,23 | 79,73 | +0,54% | 1,70% | 8.470.400 |
| 22/03/2022 | 79,27 | 79,78 | 78,77 | 79,30 | +0,30% | 1,27% | 10.016.600 |
| 21/03/2022 | 79,67 | 80,45 | 78,91 | 79,06 | -0,06% | 1,93% | 10.478.300 |
| 18/03/2022 | 79,18 | 79,74 | 78,63 | 79,11 | +0,22% | 1,40% | 21.064.800 |
| 17/03/2022 | 78,15 | 79,37 | 78,06 | 78,94 | +1,05% | 1,68% | 10.279.400 |
| 16/03/2022 | 78,96 | 79,11 | 77,65 | 78,12 | -0,66% | 1,85% | 10.944.000 |
| 15/03/2022 | 77,68 | 79,01 | 77,40 | 78,64 | +1,11% | 2,07% | 11.403.000 |
| 14/03/2022 | 77,90 | 78,61 | 77,31 | 77,78 | -0,61% | 1,67% | 10.085.400 |
| 11/03/2022 | 78,32 | 79,63 | 78,20 | 78,26 | +0,48% | 1,83% | 9.424.500 |
| 10/03/2022 | 77,63 | 78,20 | 77,33 | 77,89 | +0,13% | 1,12% | 8.972.200 |
| 09/03/2022 | 77,62 | 78,22 | 77,05 | 77,79 | +1,09% | 1,51% | 9.746.000 |
| 08/03/2022 | 77,25 | 78,09 | 76,56 | 76,95 | -1,00% | 1,98% | 10.184.100 |
| 07/03/2022 | 77,01 | 78,29 | 76,08 | 77,73 | -0,13% | 2,87% | 14.008.400 |
| 04/03/2022 | 76,68 | 77,86 | 76,02 | 77,83 | +0,88% | 2,40% | 12.216.300 |
| 03/03/2022 | 76,77 | 77,54 | 76,41 | 77,15 | +0,63% | 1,47% | 8.191.100 |
| 02/03/2022 | 76,31 | 77,22 | 76,06 | 76,67 | +0,43% | 1,52% | 9.697.500 |
| 01/03/2022 | 76,50 | 77,76 | 75,95 | 76,34 | -0,31% | 2,37% | 9.807.300 |
| 28/02/2022 | 75,83 | 76,76 | 74,78 | 76,58 | +0,34% | 2,61% | 14.126.100 |
| 25/02/2022 | 74,20 | 77,29 | 74,17 | 76,32 | +3,82% | 4,20% | 13.665.900 |
| 24/02/2022 | 75,10 | 75,32 | 72,88 | 73,51 | -3,07% | 3,25% | 21.135.600 |
| 23/02/2022 | 76,19 | 76,44 | 75,62 | 75,84 | -0,14% | 1,08% | 9.659.100 |
| 22/02/2022 | 76,46 | 76,86 | 75,61 | 75,95 | -0,55% | 1,63% | 9.052.500 |
| 18/02/2022 | 76,32 | 76,86 | 75,89 | 76,37 | +0,01% | 1,27% | 8.780.500 |